0001596771-18-000011.txt : 20180130 0001596771-18-000011.hdr.sgml : 20180130 20180130162041 ACCESSION NUMBER: 0001596771-18-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180128 FILED AS OF DATE: 20180130 DATE AS OF CHANGE: 20180130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATHIESEN JEFFREY S CENTRAL INDEX KEY: 0001296853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 18559331 MAIL ADDRESS: STREET 1: 43334 SEVEN MILE RD. STREET 2: SUITE 1000 CITY: NORTHVILLE STATE: MI ZIP: 48167 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemphire Therapeutics Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 BUSINESS PHONE: 248-980-6538 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-01-28 0 0001638287 Gemphire Therapeutics Inc. GEMP 0001296853 MATHIESEN JEFFREY S 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 0 1 0 0 Chief Financial Officer Employee Stock Option (right to buy) 10.1 2018-01-28 4 A 0 48000 0 A 2028-01-27 Common Stock 48000 48000 D The option vests in a series of 48 successive equal monthly installments on the last day of each month, commencing on the grant date. /s/ Stephanie Swan, by Power of Attorney 2018-01-30